ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0988

Risk Prediction Models for Incident Systemic Lupus Erythematosus Using Lifestyle/Environmental Risk Factors and a Genetic Risk Score

Jing Cui1, Susan Malspeis1, May Choi2, Bing Lu3, Jeffrey Sparks4, Kazuki Yoshida4 and Karen Costenbader5, 1Brigham Women's Hospital, Boston, MA, 2Brigham and Women's Hospital | University of Calgary, Calgary, AB, Canada, 3Brigham and Women's Hospital and Harvard Medical School, Newton, MA, 4Brigham and Women's Hospital, Boston, MA, 5Brigham and Women's Hospital, Belmont, MA

Meeting: ACR Convergence 2021

Keywords: Environmental factors, Lifestyle, PREDICTION, Systemic lupus erythematosus (SLE), weighted genetic risk score (wGRS)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: Epidemiology & Public Health I: Risk in Rheumatic Diseases (0988–0991)

Session Type: Abstract Session

Session Time: 4:00PM-4:15PM

Background/Purpose: The identification of lifestyle/environmental and genetic factors, influencing SLE risk introduces the potential to develop risk prediction models. We examined SLE risk prediction incorporating a lifestyle/environmental factors and a genetic risk score for SLE in predicting SLE risk among women in the prospective Nurses’ Health Studies (NHS).

Methods: Within the prospective cohorts of female nurses, Nurses’ Health Study (NHS) (1976-2016) and NHSII (1989-2018), lifestyle, environmental, and medical data were collected at baseline and on subsequent biennial questionnaires. Incident physician diagnosed SLE was self-reported on biennial questionnaires and confirmed by medical record review to meet 1997 ACR classification criteria. Genotyping was performed on blood samples collected in 1989 (NHS) and 1997 (NHSII) from ~25% of participants. We conducted a nested case-control study in which women who had donated a blood sample and developed incident SLE were matched on age (± 4 years) and race to women who had donated a blood sample but did not develop SLE. Our previously derived and published SLE weighted genetic risk score, (wGRS, Cui J et al, Arthritis Rheum, 2019) includes 86 single nucleotide polymorphisms (SNPs) and 10 classical HLA alleles associated with SLE risk. Lifestyle/environmental variables, including smoking, alcohol use, socioeconomic status, U.S. region, menarchal age, oral contraceptive use, menopausal status/postmenopausal hormone use, body mass index, were assessed on the questionnaire prior to SLE diagnosis (or matched index date). We used multivariable logistic regression to develop sequential models of SLE risk prediction, calculating the area under the receiver operating characteristic curve (AUC). Three models were generated: 1) SLE wGRS, 2) age, race, cohort, lifestyle and environmental factors and 3) model 2 + SLE wGRS. Models were internally validated using a bootstrapped estimate of optimism of the AUC. This measure of overfitting is based on average difference between predictive ability of model using original sample, and that of models using each bootstrap sample.

Results: 138 incident cases of SLE were matched to 1136 women who did not develop SLE. Characteristics of the SLE cases and their matched controls are shown in Table. The results of our three successive prediction models are shown in Figure. The expanded model 3, including both lifestyle and genetic factors, had the best discrimination, with an AUC of 0.721 and optimism corrected AUC of 0.691.

Conclusion: A combination of lifestyle and environmental factors and weighted genetic risk score accurately classified future SLE risk with good AUC of 0.721. To our knowledge, this is the first SLE prediction model using environmental and genetic factors and might be feasibly employed in at-risk populations. The NHS cohorts include few non-White women with blood samples, and mean age at incident SLE was in early 50s given enrollment age, limiting generalizability and calling for further research in more diverse cohorts.


Disclosures: J. Cui, None; S. Malspeis, None; M. Choi, MitogenDx, 1, 2; B. Lu, None; J. Sparks, Bristol-Myers Squibb, 2, 5, Amgen, 5, Gilead, 2, Inova, 2, Janssen, 2, Optum, 2, Pfizer, 2; K. Yoshida, None; K. Costenbader, Neutrolis, 11, Merck, Exagen, Gilead, 5, Astra Zeneca, Neutrolis, 2.

To cite this abstract in AMA style:

Cui J, Malspeis S, Choi M, Lu B, Sparks J, Yoshida K, Costenbader K. Risk Prediction Models for Incident Systemic Lupus Erythematosus Using Lifestyle/Environmental Risk Factors and a Genetic Risk Score [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/risk-prediction-models-for-incident-systemic-lupus-erythematosus-using-lifestyle-environmental-risk-factors-and-a-genetic-risk-score/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-prediction-models-for-incident-systemic-lupus-erythematosus-using-lifestyle-environmental-risk-factors-and-a-genetic-risk-score/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology